BFM
CERE

Boothbay Fund Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Boothbay Fund Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-73,395
Closed -$3M – 1824
2024
Q2 		$3M Buy
+73,395
New +$3M 0.07% 305
2022
Q4 		– Sell
-33,959
Closed -$960K – 2229
2022
Q3 		$960K Buy
+33,959
New +$960K 0.02% 790